Targeting this newly identified lnc-OPHN1-5/AR/hnRNPA1 complex with a small molecule like shhnRNPA1 could then lead to an increase in Enz sensitivity to better suppress PCa progression. The gene discussed is OPHN1; the disease is posterior cortical atrophy.